#

The 8th Hong Kong International Oncology Symposium

Controversies arise as we are trying to apply new technologies and treatments in the daily care of cancer patients. The only gold standard assessing clinical utility and safety is by clinical trials. However, the medical community still needs to discuss and arrive at a consensus with regard to the practical clinical management in the interim before full scientific data are available. The 8th Hong Kong International Oncology Symposium was held on 6th & 7th November 2021, with over 300 attendees and 18 speakers, both online and offline. 


Abstract Submission Method
Email: HKIOS2021@gmail.com